Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy

Prof Pierre Feugier - University of Lorraine, Nancy, France
ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy ( Prof Pierre Feugier - University of Lorraine, Nancy, France )
17 Jun 2018

Novel CD22 CAR-T therapy for paediatric leukaemia

Dr Jing Pan - Beijing Boren Hospital, Beijing, China
Novel CD22 CAR-T therapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018

Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma

Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma ( Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain )
16 Jun 2018

EHA 2018: Research, collaboration and working towards cures

Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland
EHA 2018: Research, collaboration and working towards cures ( Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland )
16 Jun 2018

Educational focus on immunotherapy at EHA

Prof John Gribben - Barts Cancer Institute, London, United Kingdom
Educational focus on immunotherapy at EHA ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018

A new anti-CD22 CAR T immunotherapy for paediatric leukaemia

Dr Jing Pan - Beijing Boren Hospital, Beijing, China
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018

EHA Topics in focus : Immunotherapy

Prof John Gribben - Barts Cancer Institute, London, United Kingdom
EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018

Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma

Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018

Interim results of RELEVANCE trial in follicular lymphoma

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Interim results of RELEVANCE trial in follicular lymphoma ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

Disease control in advanced Hodgkin lymphoma

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Improved OS with obinutuzumab in the CLL11 study

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018

Rituximab in combination therapies for FL: Interim results

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation